Session Information

Presidential Plenary Clinical

Date: Sunday, November 6th
Time: 9:00 - 10:30 AM EST
Room: Ballroom ABC

About the Session

Improve knowledge of epidemiology, diagnosis or management of hepatitis C, NAFLD, genetic cholestasis, Covid-19 and the liver, and acute kidney injury.

Learning Objectives

  • After participating in the activity, learners will be able to use a new approach to treatment of hepatitis C in patients with solid organ transplants.
  • After participating in the activity, learners will have improved knowledge of non-invasive tests of NAFLD and better understand progression of NAFLD in patients with and without diabetes
  • After participating in the activity, learners will be aware of the difference in vaccination with three vs two doses of mRNA Covid-19 vaccines in patients with cirrhosis

Abstracts

Speakers

Dr. Binu John, MD,MPH, University of Miami and Miami VA Health System, Division of Gastroenterology and Hepatology Dr. Daniel Huang, MBBS, FRCP(UK), MMED, Yong Loo Lin School of Medicine, National University of Singapore, Department of Medicine Prof. Shiv Kumar Sarin, MD, FAASLD, Institute of Liver and Biliary Sciences Dr. Calvin Q. Pan, MD, MACP, FACG, FAASLD, Division of Gastroenterology and Hepatology, Department of Medicine, NYU Langone Health, NYU Grossman School of Medicine, New York，USA. Dr. Brett Hoskins, The Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA, Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics Dr. Ferenc E Mozes, University of Oxford, Radcliffe Department of Medicine, Cardiovascular Medicine